Onyx Bridge Wealth Group’s Biogen BIIB Stock Holding History

Onyx Bridge Wealth Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,360	Closed	-$387K	–	237
2023 Q2	$387K	Buy	+1,360	New	+$405K	0.09%	151

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Onyx Bridge Wealth Group's BIIB Position: Q3 2023 in Review

Onyx Bridge Wealth Group sold out of Biogen (BIIB) in Q3 2023, closing a stake of 1,360 shares — an estimated $387K sold.

Onyx Bridge Wealth Group first reported a position in BIIB in Q2 2023 and held it in 1 quarter. The position peaked at $387K in Q2 2023. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

Onyx Bridge Wealth Group reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
Onyx Bridge Wealth Group sold 1,360 Biogen shares in Q3 2023, an estimated $387K.
Onyx Bridge Wealth Group first reported a position in Biogen in Q2 2023 and held it in 1 quarter.
Onyx Bridge Wealth Group's Biogen position peaked at $387K in Q2 2023.
965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Onyx Bridge Wealth Group's 13F filing for Q3 2023, filed 16 Oct 2023.